Integra LifeSciences Holdings (IART)

Net profit margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net income	US$ in thousands	-6,944	67,741	180,550	169,075	133,892
Revenue	US$ in thousands	1,608,880	1,486,360	1,506,670	1,533,950	1,298,690
Net profit margin		-0.43%	4.56%	11.98%	11.02%	10.31%

December 31, 2024 calculation

Net profit margin = Net income ÷ Revenue
= $-6,944K ÷ $1,608,880K
= -0.43%

Based on the provided data, Integra LifeSciences Holdings has exhibited varying levels of net profit margins over the years. The net profit margin, which represents the percentage of revenue that translates into profit after accounting for all expenses, increased from 10.31% as of December 31, 2020, to 11.02% by December 31, 2021, indicating improved profitability.

Further, the net profit margin continued to rise to 11.98% by December 31, 2022, signaling a positive trend in the company's ability to generate profits relative to its revenue. However, there was a significant decline in the net profit margin to 4.56% by December 31, 2023, which might suggest challenges or changes in the company's financial performance during that period.

Moreover, the net profit margin turned negative, reaching -0.43% by December 31, 2024, implying that Integra LifeSciences Holdings incurred losses instead of profits during that period. This negative net profit margin could be a cause for concern as it may indicate financial difficulties or operating challenges faced by the company in that particular year.

In conclusion, the analysis of Integra LifeSciences Holdings' net profit margin indicates fluctuations in profitability over the years, with a general positive trend up to 2022 but followed by a significant decline and subsequent negative margins in the later years. This suggests the importance of closely monitoring the company's financial performance and implementing strategies to improve profitability and financial health.